Estimates Revisions Arcus Biosciences, Inc.
Stocks
RCUS
US03969F1093
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
21:45:53 23/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 26.12 USD | -2.77% |
|
+5.52% | +9.15% |
| 09-16 | TD Cowen Initiates Arcus Biosciences at Buy | MT |
| 09-15 | Arcus Biosciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 12:20 PM |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RCUS Stock
- Consensus Arcus Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
